A randomized comparative study of artemisinine (qinghaosu) suppositories and oral quinine in acute falciparum malaria
- PMID: 2091337
- DOI: 10.1016/0035-9203(90)90012-4
A randomized comparative study of artemisinine (qinghaosu) suppositories and oral quinine in acute falciparum malaria
Abstract
In adult patients with acute falciparum malaria in Ho Chi Minh City, Vietnam, a more rapid reduction in parasite count (50% clearance in 11.3 h) and complete clearance (41.8 h) was obtained in 32 adult patients randomly assigned to received artemisinine suppositories than was obtained with 30 patients receiving oral quinine (20.8 h and 68.1 h). There were higher degrees of resistance (RII, 3 cases; RI early, 1 case) with quinine than with artemisinine but in a subgroup of patients quinine reduced parasitaemia as rapidly as artemisinine (50% clearance 13.6 h and 10.1 h respectively). Recrudescence (RI, delayed), occurred in 16 patients receiving artemisinine compared with 6 receiving quinine. Artemisinine suppositories, because of ease of administration, efficacy, and lack of side effects or risk of overdose, have advantages for the early treatment of falciparum malaria by possibly reducing the morbidity and mortality associated with a high or sustained parasitaemia.
Similar articles
-
Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria.Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):688-91. doi: 10.1016/0035-9203(94)90231-3. Trans R Soc Trop Med Hyg. 1994. PMID: 7886773 Clinical Trial.
-
Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria.Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):210-1. doi: 10.1016/0035-9203(91)90024-s. Trans R Soc Trop Med Hyg. 1991. PMID: 1887472 Clinical Trial. No abstract available.
-
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.Bull World Health Organ. 1994;72(2):233-8. Bull World Health Organ. 1994. PMID: 8205643 Free PMC article. Clinical Trial.
-
Emerging drug--resistance and guidelines for treatment of malaria.J Coll Physicians Surg Pak. 2004 May;14(5):319-24. J Coll Physicians Surg Pak. 2004. PMID: 15225468 Review.
-
The role of the qinghaosu derivatives in the treatment of severe malaria.Med Trop (Mars). 1998;58(3 Suppl):59-60. Med Trop (Mars). 1998. PMID: 10212901 Review.
Cited by
-
Breaking the cycle of malaria treatment failure.Front Epidemiol. 2022 Dec 14;2:1041896. doi: 10.3389/fepid.2022.1041896. eCollection 2022. Front Epidemiol. 2022. PMID: 38455307 Free PMC article.
-
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.Malar J. 2009 Jul 10;8:152. doi: 10.1186/1475-2875-8-152. Malar J. 2009. PMID: 19589177 Free PMC article.
-
Susceptibility of Pneumocystis carinii to artemisinin in vitro.Antimicrob Agents Chemother. 1991 Jun;35(6):1225-7. doi: 10.1128/AAC.35.6.1225. Antimicrob Agents Chemother. 1991. PMID: 1929266 Free PMC article.
-
The decline of malaria in Vietnam, 1991-2014.Malar J. 2018 Jun 7;17(1):226. doi: 10.1186/s12936-018-2372-8. Malar J. 2018. PMID: 29880051 Free PMC article.
-
General Pharmacology of Artesunate, a Commonly used Antimalarial Drug:Effects on Central Nervous, Cardiovascular, and Respiratory System.Toxicol Res. 2010 Sep;26(3):223-32. doi: 10.5487/TR.2010.26.3.223. Toxicol Res. 2010. PMID: 24278528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical